UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized Phase II Trial of the Efficacy and Safety of Trastuzumab Combined With Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Administered As First-Line Treatment: The M77001 Study Group

Journal of clinical oncology, 2005-07, Vol.23 (19), p.4265-4274

2005

Volltextzugriff (PDF)

Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers

Cancer research (Chicago, Ill.), 2006-05, Vol.66 (9), p.4636-4644

2006

Volltextzugriff (PDF)

Actualité des conflits d’intérêts en médecine. Des intérêts financiers à la course à la publication scientifique

Bulletin du cancer, 2021-07, Vol.108 (7-8), p.677-685

Maraninchi, Dominique

2021

Volltextzugriff (PDF)

Santé, art et spiritualité : l’installation du mètre cube d’infini de Michelangelo Pistoletto au centre de lutte contre le cancer de Marseille

Maghreb, Machrek, 2023-05, Vol.N° 252-253 (3), p.75-82

Maraninchi, Dominique

2023

Volltextzugriff (PDF)

Phase III Double-Blind, Placebo-Controlled Study of Thalidomide in Extensive-Disease Small-Cell Lung Cancer After Response to Chemotherapy: An Intergroup Study FNCLCC cleo04–IFCT 00-01

Journal of clinical oncology, 2007-09, Vol.25 (25), p.3945-3951

2007

Volltextzugriff (PDF)

Protein expression profiling identifies subclasses of breast cancer and predicts prognosis

Cancer research (Chicago, Ill.), 2005-02, Vol.65 (3), p.767-779

2005

Volltextzugriff (PDF)

Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy

Cancer research (Chicago, Ill.), 2004-12, Vol.64 (23), p.8558-8565

2004

Volltextzugriff (PDF)

Tumoral and Immunologic Response After Vaccination of Melanoma Patients With an ALVAC Virus Encoding MAGE Antigens Recognized by T Cells

Journal of clinical oncology, 2005-12, Vol.23 (35), p.9008-9021

2005

Volltextzugriff (PDF)

How different are luminal A and basal breast cancers?

International journal of cancer, 2009-03, Vol.124 (6), p.1338-1348

2009

Volltextzugriff (PDF)

Cancer : le besoin de croire

Bulletin du cancer, 2024-06, Vol.111 (6), p.550-551

2024

Volltextzugriff (PDF)

Early Allogeneic Stem-Cell Transplantation for Young Adults With Acute Myeloblastic Leukemia in First Complete Remission: An Intent-to-Treat Long-Term Analysis of the BGMT Experience

Journal of clinical oncology, 2005-10, Vol.23 (30), p.7676-7684

2005

Volltextzugriff (PDF)

Patient participation in medical decision-making: From concept to reality in oncology

Bulletin du cancer, 2017-07, Vol.104 (7-8), p.695

2017

Volltextzugriff (PDF)

Identification of new classes among acute myelogenous leukaemias with normal karyotype using gene expression profiling

Oncogene, 2004-12, Vol.23 (58), p.9381-9391

2004

Volltextzugriff (PDF)

Assessment of Care by Breast Cancer Patients Participating or Not Participating in a Randomized Controlled Trial: A Report With the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer

Journal of clinical oncology, 2007-07, Vol.25 (21), p.3038-3044

2007

Volltextzugriff (PDF)

The use of ‘added benefit’ to determine the price of new anti-cancer drugs in France, 2004–2017

European journal of cancer (1990), 2021-03, Vol.145, p.11-18

2021

Volltextzugriff (PDF)

Corrigendum to “The use of ‘added benefit’ to determine the price of new anti-cancer drugs in France, 2004–2017” [Eur J Canc 145 (2021) 11–18]

European journal of cancer (1990), 2021-07, Vol.152, p.259-261

2021

Volltextzugriff (PDF)

Médicaments du cancer : quelles innovations et à quel prix ?

Bulletin du cancer, 2016-04, Vol.103 (4), p.361-367

2016

Volltextzugriff (PDF)

Un cancérologue indépendant à la tête de l’Afssaps « Priorité au progrès, à la transparence et à la communication

Oncomagazine, 2011-08, Vol.5 (3), p.6-6

Maraninchi, Dominique

2011

Volltextzugriff (PDF)

L’autonomie de décision du patient : du concept à la pratique cancérologique

Bulletin du cancer, 2017-07, Vol.104 (7-8), p.695-700

2017

Volltextzugriff (PDF)

Anticancer drugs: Which prices for therapeutic innovations?

Bulletin du cancer, 2016-04, Vol.103 (4), p.361

2016

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Escalating Dose of Docetaxel Administered with Granulocyte Colony-stimulating Factor Support in Adult Advanced Solid Tumors

Clinical cancer research, 2003-01, Vol.9 (1), p.102-108

2003

Volltextzugriff (PDF)

Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia

Cancer, 2007-04, Vol.109 (7), p.1376-1383

2007

Volltextzugriff (PDF)

Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia

Blood, 2011-06, Vol.117 (26), p.7007-7013

2011

Volltextzugriff (PDF)

E-health and "Cancer outside the hospital walls", Big Data and artificial intelligence

Bulletin du cancer, 2020-01, Vol.107 (1), p.102

2020

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(101)

Publikationsform

Sprache

Englisch
(110)
Französisch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized Phase II Trial of the Efficacy and Safety of Trastuzumab Combined With Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Administered As First-Line Treatment: The M77001 Study Group

Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers

Actualité des conflits d’intérêts en médecine. Des intérêts financiers à la course à la publication scientifique

Santé, art et spiritualité : l’installation du mètre cube d’infini de Michelangelo Pistoletto au centre de lutte contre le cancer de Marseille

Phase III Double-Blind, Placebo-Controlled Study of Thalidomide in Extensive-Disease Small-Cell Lung Cancer After Response to Chemotherapy: An Intergroup Study FNCLCC cleo04–IFCT 00-01

Protein expression profiling identifies subclasses of breast cancer and predicts prognosis

Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy

Tumoral and Immunologic Response After Vaccination of Melanoma Patients With an ALVAC Virus Encoding MAGE Antigens Recognized by T Cells

How different are luminal A and basal breast cancers?

Cancer : le besoin de croire

Early Allogeneic Stem-Cell Transplantation for Young Adults With Acute Myeloblastic Leukemia in First Complete Remission: An Intent-to-Treat Long-Term Analysis of the BGMT Experience

Patient participation in medical decision-making: From concept to reality in oncology

Identification of new classes among acute myelogenous leukaemias with normal karyotype using gene expression profiling

Assessment of Care by Breast Cancer Patients Participating or Not Participating in a Randomized Controlled Trial: A Report With the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer

The use of ‘added benefit’ to determine the price of new anti-cancer drugs in France, 2004–2017

Corrigendum to “The use of ‘added benefit’ to determine the price of new anti-cancer drugs in France, 2004–2017” [Eur J Canc 145 (2021) 11–18]

Consolidation Treatment of Adult Acute Lymphoblastic Leukemia: A Prospective, Randomized Trial Comparing Allogeneic Versus Autologous Bone Marrow Transplantation and Testing the Impact of Recombinant Interleukin-2 After Autologous Bone Marrow Transplantation

Médicaments du cancer : quelles innovations et à quel prix ?

Un cancérologue indépendant à la tête de l’Afssaps « Priorité au progrès, à la transparence et à la communication

L’autonomie de décision du patient : du concept à la pratique cancérologique

Anticancer drugs: Which prices for therapeutic innovations?

Phase I and Pharmacokinetic Study of Escalating Dose of Docetaxel Administered with Granulocyte Colony-stimulating Factor Support in Adult Advanced Solid Tumors

Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia

Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia

E-health and "Cancer outside the hospital walls", Big Data and artificial intelligence

Suchergebnisse filtern